1417 results
-
List item
News: Clinical Trials Information System reaches major milestone towards go-live and application of the Clinical Trial Regulation (new)
MB, Last updated: 21/04/2021 -
List item
Extraordinary Management Board meeting on CTIS audit (new)
European Medicines Agency, Amsterdam, the Netherlands, 21/04/2021, Last updated: 20/04/2021 -
List item
News: Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 13-15 April 2021 (new)
CVMP, Last updated: 16/04/2021 -
List item
News: EMA starts review of VIR-7831 for treating patients with COVID-19 (new)
CHMP, Last updated: 15/04/2021 -
List item
News: AstraZeneca’s COVID-19 vaccine: EMA to provide further context on risk of very rare blood clots with low blood platelets (new)
CHMP, Last updated: 14/04/2021 -
List item
Committee for Medicinal Products for Human Use (CHMP): 24-27 January 2022 (new)
European Medicines Agency, Amsterdam, the Netherlands, from 24/01/2022 to 27/01/2022, Last updated: 06/04/2021 -
List item
Committee for Medicinal Products for Human Use (CHMP): 21-24 February 2022 (new)
European Medicines Agency, Amsterdam, the Netherlands, from 21/02/2022 to 24/02/2022, Last updated: 06/04/2021 -
List item
Committee for Medicinal Products for Human Use (CHMP): 21-24 March 2022 (new)
European Medicines Agency, Amsterdam, the Netherlands, from 21/03/2022 to 24/03/2022, Last updated: 06/04/2021 -
List item
Committee for Medicinal Products for Human Use (CHMP): 19-22 April 2022 (new)
European Medicines Agency, Amsterdam, the Netherlands, from 19/04/2022 to 22/04/2022, Last updated: 06/04/2021 -
List item
Committee for Medicinal Products for Human Use (CHMP): 16-19 May 2022 (new)
European Medicines Agency, Amsterdam, the Netherlands, from 16/05/2022 to 19/05/2022, Last updated: 06/04/2021 -
List item
Committee for Medicinal Products for Human Use (CHMP): 20-23 June 2022 (new)
European Medicines Agency, Amsterdam, the Netherlands, from 20/06/2022 to 23/06/2022, Last updated: 06/04/2021 -
List item
Committee for Medicinal Products for Human Use (CHMP): 18-21 July 2022 (new)
European Medicines Agency, Amsterdam, the Netherlands, from 18/07/2022 to 21/07/2022, Last updated: 06/04/2021 -
List item
Committee for Medicinal Products for Human Use (CHMP): 16-19 August 2022 (new)
Written procedure, from 16/08/2022 to 19/08/2022, Last updated: 06/04/2021 -
List item
Committee for Medicinal Products for Human Use (CHMP): 12-15 September 2022 (new)
European Medicines Agency, Amsterdam, the Netherlands, from 12/09/2022 to 15/09/2022, Last updated: 06/04/2021 -
List item
Committee for Medicinal Products for Human Use (CHMP): 10-13 October 2022 (new)
European Medicines Agency, Amsterdam, the Netherlands, from 10/10/2022 to 13/10/2022, Last updated: 06/04/2021 -
List item
Committee for Medicinal Products for Human Use (CHMP): 7-10 November 2022 (new)
European Medicines Agency, Amsterdam, the Netherlands, from 07/11/2022 to 10/11/2022, Last updated: 06/04/2021 -
List item
Committee for Medicinal Products for Human Use (CHMP): 12-15 December 2022 (new)
European Medicines Agency, Amsterdam, the Netherlands, from 12/12/2022 to 15/12/2022, Last updated: 06/04/2021 -
List item
News: Increase in vaccine manufacturing capacity and supply for COVID-19 vaccines from AstraZeneca, BioNTech/Pfizer and Moderna (new)
CHMP, Last updated: 26/03/2021 -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 22-25 March 2021 (new)
CHMP, Last updated: 26/03/2021 -
List item
News: EMA issues advice on use of regdanvimab for treating COVID-19 (new)
CHMP, Last updated: 26/03/2021 -
List item
News: Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 16-18 March 2021
CVMP, Last updated: 19/03/2021 -
List item
News: EMA Management Board – highlights of March 2021 meeting
MB, Last updated: 12/03/2021 -
List item
News: EMA recommends COVID-19 Vaccine Janssen for authorisation in the EU
CHMP, Last updated: 11/03/2021 -
List item
News: EMA starts rolling review of Eli Lilly antibodies bamlanivimab and etesevimab for COVID-19
CHMP, Last updated: 11/03/2021 -
List item
Management Board meeting: 11 March 2021
European Medicines Agency, Amsterdam, the Netherlands, 11/03/2021, Last updated: 12/03/2021